Indivumed Therapeutics
Curated by SignalAI-powered platform to discover novel therapeutic targets through precision oncology
Overview
AI-powered platform to discover novel therapeutic targets through precision oncology. The company utilizes nRavel with unique datasets to drive the discovery of therapeutic drug targets, the assessment of molecular signaling pathways, and the identification of biomarkers and gene signatures for the stratification of cancer patients.
Key facts
- Founded
- 2002
- Headquarters
- Hamburg, Germany
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 5 products and services
- Sign up to view
Contact
- Sign up to view
- Phone
- Sign up to view
Open roles
1 roleDirector Bioinformatics (m/f/d)
Hamburg, Hamburg, Germany · On-site · Full-time